USE OF FUSED HETEROCYCLIC COMPOUNDS AS SCCE INHIBITORS FOR THE TREATMENT OF SKIN CONDITIONS OR CANCER
申请人:Arexis AB
公开号:EP1631295A2
公开(公告)日:2006-03-08
Use of heterocyclic compounds as scce inhibitors
申请人:Linschoten Marcel
公开号:US20060258651A1
公开(公告)日:2006-11-16
The present invention relates to heterocyclic inhibitors of stratum corneum chymotryptic enzyme (SCCE). More particularly, the invention relates to the use of compounds with the formula (I) or (II) for treatment of certain diseases, in particular skin diseases such as pruirtus, as well as cancer such as ovarian cancer.
US7872052B2
申请人:——
公开号:US7872052B2
公开(公告)日:2011-01-18
[EN] USE OF HETEROCYCLIC COMPOUNDS AS SCCE INHIBITORS<br/>[FR] UTILISATION DE COMPOSES HETEROCYCLIQUES EN TANT QU'INHIBITEURS DE SCCE
申请人:AREXIS AB
公开号:WO2004108139A2
公开(公告)日:2004-12-16
The present invention relates to heterocyclic inhibitors of stratum corneum chymotryptic enzyme (SCCE). More particularly, the invention relates to the use of compounds with the formula (I) or (II) for treatment of certain diseases, in particular skin diseases such as pruirtus, as well as cancer such as ovarian cancer.
Agarwal, Journal of the Indian Chemical Society, 1991, vol. 68, # 2, p. 85 - 87